ArticleScientific reports2026
A rare mutation (p.Ala264Thr) of GATA4 is responsible for atrial septal defect and pulmonary valve stenosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Atrial septal defect (ASD) is a type of congenital heart defect characterized by the absence of atrial septal tissue. Research has shown that genetic factors play a significant role in the development of ASD. Variants in genes such as GATA binding protein 4 (GATA4), NK2 homeobox 5, and T-box transcription factor 5 have been identified in patients with ASD. In this study, we enrolled a Chinese family affected by ASD and PS. Whole exome sequencing and Sanger sequencing were used to investigate the genetic basis of lesions in this family. The AC16 cell line was used to perform the functional study. After data filtering and co-segregation analysis, we identified a rare mutation (NM_001308093.3: c.790G > A, p.Ala264Thr) in the GATA4 gene in the affected family members that was absent in the unaffected individuals. Bioinformatic analysis revealed that the newly identified mutation was deleterious and altered the hydrophobicity, size and polar of the GATA4 protein. Functional studies revealed that this rare mutation disrupted the stability of GATA4 and reduced the ability of GATA4 to activate the downstream target genes. Our findings highlight the importance of the N-terminal zinc finger structure of GATA4 in cardiac development. Additionally, our study contributes to the genetic diagnosis and counseling of families with congenital heart disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.